Medigen Biotechnology Corp. Stock

MEDIGEN BIOTECHNOLOGY CORP. is a Taiwan-based company principally engaged in the wholesales and distribution of general drugs. The Company is engaged in the licensing of technologies, the provision of technical services and testing services of nucleic acids. The Company's products and services include human leukocyte antigen (HLA) ABDR typing reagents, HLA typing and testing services, HLA SBT high-resolution typing reagents, HLA ABCDRDQ typing kits, nucleic acid testing reagents for the genotyping of human platelet, nucleic acid extraction instruments and reagents and blood screening specialized automated nucleic acid detection platforms. It also provides medical beauty care products. The Company distributes its products in Taiwan market and to overseas markets.